← Pipeline
Registered human trialRecruitingNo efficacy data yet
Phase 2
ReCOVER
Clemastine • acute optic neuritis
Practical availability: Research study — recruiting does not guarantee access
- Compound / intervention
- Clemastine • acute optic neuritis
- Mechanism
- Clemastine; muscarinic-receptor antagonism
- Development stage
- Phase 2
- Status
- Recruiting
- Population / locations
- Site: UCSF, US • no Greek site
- Evidence level
- Human Phase 2 • results pending
Next substantive checkpoint
VEP and MRI remyelination evidence • estimated completion 2028
Related substantive developments
No separate substantive update is currently linked.